
Junicef-S 1gm/0.5gm Injection
Marketer
Junifer Pharmaceuticals
Salt Composition
Ceftriaxone (1gm) + Sulbactam (0.5gm)
Overview Junicef-S 1gm/0.5gm Injection
Combiflox-S 1g/0.5g injection is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, halting infection progression. Administration must be strictly under medical guidance; missed doses should be avoided, and the full treatment course completed regardless of symptom improvement. Premature cessation may compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical consultation. Allergic reactions (rash, pruritus, edema, dyspnea) demand prompt medical attention. Prior to use, inform your physician of all concurrent medications and pre-existing conditions. Pregnant or lactating individuals should seek medical advice before use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, drowsiness or dizziness warrants abstention from driving. Adequate rest, balanced nutrition, and hydration are crucial for optimal recovery. Your doctor may order blood tests and other investigations to monitor treatment response.
Primary Ingredients of Junicef-S 1gm/0.5gm Injection
There is no text provided to rephrase.
Uses of Junicef-S 1gm/0.5gm Injection
Infections caused by bacteria
Major Benefits of Junicef-S 1gm/0.5gm Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Junicef-S 1gm/0.5gm Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Junicef-S 1gm/0.5gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Junicef-S 1gm/0.5gm Injection works:
Ceftriaxone and Sulbactam, combined as Junicef-S 1gm/0.5gm Injection, offer a dual-action approach to bacterial infection. Ceftriaxone's antibiotic properties disrupt bacterial cell wall synthesis, hindering their survival. Sulbactam, a beta-lactamase inhibitor, complements this action by countering bacterial resistance mechanisms, thus optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between alcohol consumption and Junicef-S 1gm/0.5gm Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Junicef-S (1gm/0.5gm) is typically deemed safe for use during gestation. Preclinical trials using animal models revealed minimal or absent harm to offspring; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
The administration of Junicef-S 1gm/0.5gm Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Junicef-S 1gm/0.5gm Injection may induce drowsiness, blurred vision, or dizziness. Driving should be avoided if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Junicef-S 1gm/0.5gm Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Exercise caution when administering Junicef-S 1gm/0.5gm Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Junicef-S 1gm/0.5gm Injection is not advised for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Junicef-S 1gm/0.5gm Injection :
Omit a Junicef-S 1gm/0.5gm Injection dose? Seek medical advice immediately.
Facts to Know About Junicef-S 1gm/0.5gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Anti-infective agents |
